These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36093517)

  • 1. A network pharmacology-based exploration of the active compounds and potential drug targets of Si-Jun-Zi decoction in the treatment of cutaneous squamous cell carcinoma.
    Qin S; Zhang LY; Zhang HB; Shi SM; Zhou X; Lu ZY; Duan YX; Huang WB; Wen J
    Transl Cancer Res; 2022 Aug; 11(8):2887-2901. PubMed ID: 36093517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Xiaozheng decoction for anti-bladder cancer effects via affecting the GSK3β/β-catenin signaling pathways: a network pharmacology-directed experimental investigation.
    Zhuang J; Mo J; Huang Z; Yan Y; Wang Z; Cao X; Yang C; Shen B; Zhang F
    Chin Med; 2023 Aug; 18(1):104. PubMed ID: 37608369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.
    Li WH; Han JR; Ren PP; Xie Y; Jiang DY
    Comput Biol Chem; 2021 Feb; 90():107358. PubMed ID: 33243703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Baihe Decoction in the treatment of coronary heart disease based on network pharmacology and molecular docking.
    Jin Y; Yin X; Li Z; Xu J
    Ann Palliat Med; 2021 Mar; 10(3):3205-3218. PubMed ID: 33849106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of Shaofu Zhuyu Decoction in treatment of EMT induced dysmenorrhea based on network pharmacology and molecular docking].
    Chen YH; Zhang ZL; Wu QS; Feng P; Qiao XY; Zhang XH; Mao HY; Cai S; Zhou XJ
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6484-6492. PubMed ID: 34994141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach.
    Li C; Niu M; Wang R; Zhou XW; Dong B; Qi S; Chen W; Zhang M; Shi Y; Li R; Li G
    Biomed Pharmacother; 2019 Mar; 111():1132-1140. PubMed ID: 30841426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
    Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
    J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
    Ji W; Wang T; Xu Y; An R; Liang K; Wang X
    Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression.
    Bai Y; Zhang Y; Li S; Zhang W; Wang X; He B; Ju W
    Front Pharmacol; 2021; 12():711303. PubMed ID: 34690756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic material basis of Daqinglong Decoction: based on serum pharmacochemistry and network pharmacology].
    Yuan M; Sun GD; Liu HS; Huo JH; Wang WM
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3876-3886. PubMed ID: 35850846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huoxue Qingre decoction used for treatment of coronary heart disease network analysis and metabolomic evaluation.
    Tan YQ; Jin M; He XH; Chen HW
    Front Pharmacol; 2022; 13():1025540. PubMed ID: 36339536
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor Effect of Si-Jun-Zi Decoction on SGC7901 Gastric Cancer Cells by CMTM2 Activation.
    Li X; Chen W; Miao L; Sun H; Gao X; Guo S; Zhang Y; Yang Y; Guo J
    Evid Based Complement Alternat Med; 2022; 2022():4675815. PubMed ID: 35873650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
    Que DH; Chen WH; Jiang FP; Pan F; Yang K
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology and molecular docking analysis reveal insights into the molecular mechanism of shiliao decoction in the treatment of cancer-associated malnutrition.
    Long S; Ji S; Xue P; Xie H; Ma Y; Zhu S
    Front Nutr; 2022; 9():985991. PubMed ID: 36091226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction.
    Guo JF; Zhao YT; Du QY; Ren Y; Wang Y; Wang ZX; Jin W
    Biomed Res Int; 2022; 2022():2775434. PubMed ID: 35528155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy.
    Liu M; Yuan G; Luo G; Guo X; Chen M; Yang H; He F; Yang T; Zhang X; Wu Q; Zhou H; Yang S
    Evid Based Complement Alternat Med; 2022; 2022():7578055. PubMed ID: 35722148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.
    Liu X; Fan Y; Du L; Mei Z; Fu Y
    Front Pharmacol; 2021; 12():665102. PubMed ID: 34177580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification.
    Xu L; Zhang J; Wang Y; Zhang Z; Wang F; Tang X
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33409535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential mechanism of Longsheyangquan Decoction on the treatment of bladder cancer: Systemic network pharmacology and molecular docking.
    Cheng Z; Ye F; Xu C; Liang Y; Zhang Z; Chen X; Dai X; Ou Y; Mou Z; Li W; Chen Y; Zhou Q; Zou L; Mao S; Jiang H
    Front Pharmacol; 2022; 13():932039. PubMed ID: 35910372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum-Effect Relationship between UPLC Fingerprints and Antilung Cancer Effect of Si Jun Zi Tang.
    Zhou X; Li Y; Zhang M; Hao J; Gu Q; Liu H; Chen W; Shi Y; Dong B; Zhang Y; Li C; Li G
    Evid Based Complement Alternat Med; 2019; 2019():7282681. PubMed ID: 31662780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.